Progress in understanding the pathophysiology of treatment-related fluctuations in Parkinson's disease
β Scribed by G. Frederick Wooten
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 341 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro
p < 0.05 by Kruskal-Wallis for difference between the fluctuators and nonfluctuators but not between the untreated and wearing-off groups. 'p < 0.005 by analysis of variance for difference between the fluctuators and nonfluctuators but not between the uncomplicated and wearingoff groups.